Cargando…
Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neuronal function, or associated pathological features of this common neurodegenerative disease. The most widely accepted clinical PET tool for AD is 18-fluorodeoxyglucose PET (FDG-PET), which measures c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204649/ https://www.ncbi.nlm.nih.gov/pubmed/25343059 http://dx.doi.org/10.4172/2161-0460.1000143 |